Factors such as technological advancements in defibrillators, increasing burden of target diseases, growing focus on providing public-access defibrillators, and rising number of training & awareness programs on defibrillators are driving the growth of the defibrillators market.
According to the new market research report defibrillators market is projected to reach USD 10,883.3 million by 2022 from USD 9,323.5 million in 2017 at a CAGR of 3.1%. North America dominated the global defibrillators market in 2017.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=549
On the basis of products, the defibrillators market is classified into implantable cardioverter defibrillators (ICDs) and external defibrillators. The ICDs product segment is bifurcated into transvenous implantable cardioverter defibrillators (T-ICDs) and subcutaneous implantable cardioverter defibrillators (S-ICDs). The T-ICDs segment is further classified into single-chamber ICDs, dual-chamber ICDs, and cardiac resynchronization therapy defibrillators (CRT-Ds). The external defibrillators segment is further classified into manual external defibrillators, automated external defibrillators (AEDs), and wearable cardioverter defibrillators (WCDs).
Top Market Players –
ZOLL Medical (US) held the leadership position in the global external defibrillators market.
The company adopted new product launches, agreements, and partnerships as its core business strategies to enhance its share in the global external market. Other prominent players in the global external market included Philips (Netherlands), Physio-Control (US), Cardiac Science (US), Nihon Kohden (Japan), SCHILLER (Switzerland), Mindray Medical (China), Mediana (South Korea), METRAX (Germany), and METsis (Turkey).
Report Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=549
Geographic Overview –
North America is expected to account for the largest share of the global defibrillators market in 2017, followed by Europe. The large share in the North American region is mainly attributed to the rising incidence of target diseases in the region, technological advancements in defibrillators, and increasing number of public defibrillation programs in the region. The large share of the North American market can mainly be attributed to the continuous technological advancements and product innovations, increasing number of public defibrillation programs, and rising focus of key players to expand their business in the North American region.